Royalty Pharma plc (RPRX) ownership: Top institutional holder: MORGAN STANLEY ($2.09B). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| MORGAN STANLEY | 43571633.00 | $2.09B | 2026-03-31 |
| Capital International Investors | 35005736.00 | $1.68B | 2026-03-31 |
| BlackRock, Inc. | 25907745.00 | $1.24B | 2026-03-31 |
| FMR LLC | 25152242.00 | $1.21B | 2026-03-31 |
| BAILLIE GIFFORD & CO | 16155677.00 | $774.99M | 2026-03-31 |
| Swedbank AB | 11586693.00 | $555.81M | 2026-03-31 |
| STATE STREET CORP | 10989851.00 | $527.18M | 2026-03-31 |
| Capital World Investors | 8036714.00 | $385.52M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-20 | |
| Sell | null | 2026-05-14 | |
| Sell | null | 2026-05-14 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 |
Back to RPRX overview · RPRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.